CA 47829/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1989	1
1990	3
1991	3
1992	4
1993	1
1994	7
1995	4
1996	4
1997	5
1998	4
1999	9
2000	2
2001	3
2002	2
2003	6
2004	1
2005	3
2006	2
2007	1
2008	1
2024	0

1

Antiangiogenic agents and their promising potential in combined therapy.

Burke PA, DeNardo SJ. Burke PA, et al. Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):155-71. doi: 10.1016/s1040-8428(01)00115-9. Crit Rev Oncol Hematol. 2001. PMID: 11418313 Review.

2

Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and 90Y-labeled HLA-DR antibodies.

DeNardo GL, Tobin E, Chan K, Bradt BM, DeNardo SJ. DeNardo GL, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7075s-7079s. doi: 10.1158/1078-0432.CCR-1004-0008. Clin Cancer Res. 2005. PMID: 16203805

3

Combined modality radioimmunotherapy. Promise and peril.

Burke PA, DeNardo SJ, Miers LA, Kukis DL, DeNardo GL. Burke PA, et al. Cancer. 2002 Feb 15;94(4 Suppl):1320-31. doi: 10.1002/cncr.10303. Cancer. 2002. PMID: 11877763 Free article.

4

Strategies for developing effective radioimmunotherapy for solid tumors.

DeNardo GL, O'Donnell RT, Kroger LA, Richman CM, Goldstein DS, Shen S, DeNardo SJ. DeNardo GL, et al. Clin Cancer Res. 1999 Oct;5(10 Suppl):3219s-3223s. Clin Cancer Res. 1999. PMID: 10541367 Review.

5

A new era for radiolabeled antibodies in cancer?

DeNardo SJ, Kroger LA, DeNardo GL. DeNardo SJ, et al. Curr Opin Immunol. 1999 Oct;11(5):563-9. doi: 10.1016/s0952-7915(99)00017-5. Curr Opin Immunol. 1999. PMID: 10508716 Review.

6

Milestones in the development of Lym-1 therapy.

DeNardo GL, O'Donnell RT, Rose LM, Mirick GR, Kroger LA, DeNardo SJ. DeNardo GL, et al. Hybridoma. 1999 Feb;18(1):1-11. doi: 10.1089/hyb.1999.18.1. Hybridoma. 1999. PMID: 10211782 Review.

7

Human antiglobulin response to foreign antibodies: therapeutic benefit?

DeNardo GL, Bradt BM, Mirick GR, DeNardo S. DeNardo GL, et al. Cancer Immunol Immunother. 2003 May;52(5):309-16. doi: 10.1007/s00262-002-0350-y. Epub 2003 Mar 4. Cancer Immunol Immunother. 2003. PMID: 12700946 Free PMC article. Review.

8

The biologic window for chimeric L6 radioimmunotherapy.

DeNardo SJ, Mirick GR, Kroger LA, O'Grady LF, Erickson KL, Yuan A, Lamborn KR, Hellstrom I, Hellstrom KE, DeNardo GL. DeNardo SJ, et al. Cancer. 1994 Feb 1;73(3 Suppl):1023-32. doi: 10.1002/1097-0142(19940201)73:3+<1023::aid-cncr2820731341>3.0.co;2-u. Cancer. 1994. PMID: 8306244 Clinical Trial.

9

Kroger LA, DeNardo GL, Gumerlock PH, Xiong CY, Winthrop MD, Shi XB, Mack PC, Leshchinsky T, DeNardo SJ. Kroger LA, et al. Cancer Biother Radiopharm. 2001 Jun;16(3):213-25. doi: 10.1089/10849780152389401. Cancer Biother Radiopharm. 2001. PMID: 11471486

10

Effect of antilymphoma antibody, 131I-Lym-1, on peripheral blood lymphocytes in patients with non-Hodgkin's lymphoma.

Schillaci O, DeNardo GL, DeNardo SJ, Goldstein DS, Kroger LA, O'Donnell RT, Lamborn KR. Schillaci O, et al. Cancer Biother Radiopharm. 2007 Aug;22(4):521-30. doi: 10.1089/cbr.2007.374A. Cancer Biother Radiopharm. 2007. PMID: 17803447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year